Sunil Healthcare Adjusts Evaluation Score Amidst Profit Surge and Debt Concerns
Sunil Healthcare has recently adjusted its evaluation score, indicating a shift in technical trends. The company reported a significant profit increase of 109.8% over the past year, despite facing challenges such as a high debt to EBITDA ratio. Key financial metrics show improvements in profitability ratios.
Sunil Healthcare, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a sideways position to a mildly bullish outlook. The stock's current price stands at 82.00, slightly above the previous close of 81.32. Over the past year, Sunil Healthcare has experienced a return of -9.29%, contrasting with a 2.82% decline in the Sensex. However, the company has reported a notable increase in profits, with a rise of 109.8% over the same period.
Key financial metrics indicate that the operating profit to interest ratio has reached its highest level at 2.28 times, while the PBDIT for the quarter is recorded at Rs 3.28 crore. The operating profit to net sales ratio is also at a peak of 14.49%. Despite these positive indicators, the company faces challenges with a high debt to EBITDA ratio of 6.67 times and an average return on capital employed (ROCE) of 5.38%.
Overall, the adjustment in evaluation for Sunil Healthcare reflects a complex interplay of technical trends and financial performance metrics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
